About this data
What it is
The US Patent and Trademark Office (USPTO) grants new patents every Tuesday. We match the companies named as owners to public companies.
Who files it
The USPTO publishes each grant.
How current
Grants are published every Tuesday, and we collect them weekly.
Worth knowing
A patent count says little about how valuable the patents are. We match owners to companies automatically, so a few may be missed.

All of this comes from public filings.

Patents granted per week, last 12 weeks

05,00010.0K15.0KAug 25 · Patents granted: 8,093Aug 25Sep 1 · Patents granted: 6,519Sep 1Sep 8 · Patents granted: 6,822Sep 8Sep 15 · Patents granted: 6,983Sep 15Sep 22 · Patents granted: 5,563Sep 22Sep 29 · Patents granted: 6,286Sep 29Oct 6 · Patents granted: 7,272Oct 6Oct 13 · Patents granted: 8,528Oct 13Oct 20 · Patents granted: 7,948Oct 20Oct 27 · Patents granted: 5,467Oct 27Nov 3 · Patents granted: 10,067Nov 3Nov 10 · Patents granted: 8,414Nov 10
05,00010.0K15.0KAug 25 · Patents granted: 8,093Aug 25Sep 1 · Patents granted: 6,519Sep 1Sep 8 · Patents granted: 6,822Sep 8Sep 15 · Patents granted: 6,983Sep 15Sep 22 · Patents granted: 5,563Sep 22Sep 29 · Patents granted: 6,286Sep 29Oct 6 · Patents granted: 7,272Oct 6Oct 13 · Patents granted: 8,528Oct 13Oct 20 · Patents granted: 7,948Oct 20Oct 27 · Patents granted: 5,467Oct 27Nov 3 · Patents granted: 10,067Nov 3Nov 10 · Patents granted: 8,414Nov 10

Latest patent grants

Reset

Showing: ticker BMY

Latest patent grants
GrantedPatentOwnerTypeSource
Nov 10, 202612790631
Manufacturing process for protein
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
Nov 10, 202612790396
Antibodies binding to VISTA at acidic pH
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
Nov 10, 202612790392
Antibodies against human TREM-1 and uses thereof
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
Nov 3, 202612780776
Naphthalene and quinoline analogs as RXFP1 agonists
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
Oct 20, 202612770378
Medical imaging analysis using self-supervised learning
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
Oct 20, 202612767721
CD40 antagonist antibody variants with improved pharmacokinetic prope…
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
Oct 20, 202612767654
2-(4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl…
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
Oct 13, 202612760046
Phosphorous (V)-based reagents, processes for the preparation thereof…
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
Oct 13, 202612760029
KRAS G12D inhibitors
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
Oct 13, 202612759999
Indole carboxamide compounds
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
Oct 13, 202612758709
Drug cartridge, drug delivery device, and methods for preparing there…
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
Oct 13, 202612758559
RXFP1 agonists
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
Oct 6, 202612751948
Dosage forms for TYK2 inhibitors
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
Sep 29, 202612747296
Anti-CCR8 antibodies for treating cancer
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
Sep 15, 202612735488
Antibodies binding to vista at acidic pH
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
Sep 15, 202612734169
Dosage forms for Tyk2 inhibitors
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
Sep 1, 202612723041
Lactone and lactam containing compounds useful as immunomodulators
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
Aug 25, 202612715856
Compounds useful as immunomodulators
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
Aug 25, 202612714778
Drug cartridge, drug delivery devices, and methods for preparing ther…
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
Aug 18, 202612709594
RXFP1 agonists
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
Aug 4, 202612699097
M-protein assays
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
Jul 21, 202612686716
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
Jul 14, 202612680108
Miniaturized dystrophins and uses thereof
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
Jul 14, 202612679823
Oxopyrrolidine FPR2 agonists
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
Jul 7, 202612673954
Benzofuran compounds as sting agonists
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
Jul 7, 202612673042
[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
Jun 30, 202612668598
MK2 inhibitors and uses thereof
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
May 26, 202612639333
Indicating differences in and reconciling data stored in disparate da…
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
May 26, 202612637522
Monoclonal antibodies against BCMA
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
May 19, 202612630583
Methods of purifying proteins using chromatography
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
May 12, 202612624336
Methods of producing recombinant proteins
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
May 12, 202612624107
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
May 12, 202612624033
KRAS inhibitors
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
May 12, 202612622954
Anti-ICOS agonist antibodies and uses thereof
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
May 5, 202612617850
Treatment of PD-L1-positive melanoma using an anti-PD-1 antibody
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
May 5, 202612617754
Process for synthesizing lipids
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
Apr 21, 202612608626
Plug-and-analyze framework for knowledge base construction
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
Mar 31, 202612590154
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
Mar 31, 202612590153
Treatment of PD-L1-negative melanoma using an anti-PD-1 antibody and…
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
Mar 31, 202612590091
1H-pyrrolo[3,2-C]pyridine and 1H-pyrrolo[2,3-C]pyridine derivatives a…
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
Mar 24, 202612582713
Methods of treating tumors
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
Mar 17, 202612577214
Polymorphs of bis(fluoroalkyl)-1,4-benzodiazepinone compounds and use…
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
Mar 17, 202612577206
Pyrazolone formyl peptide 2 receptor agonists
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
Mar 10, 202612570671
Substituted oxoisoindoline compounds for the treatment of cancer
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
Mar 10, 202612570659
Bicyclic heteroaryl compounds useful as IRAK4 inhibitors
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
Mar 10, 202612570637
Crystalline salt forms 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1…
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
Mar 10, 202612570609
Tricyclic sulfones as ROR gamma modulators
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
Mar 3, 202612565528
LAG-3 antagonist therapy for lung cancer
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
Mar 3, 202612565487
Process for the preparation of 6-(cyclopropaneamido)-4-((2-methoxy-3-…
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗
Mar 3, 202612565483
Oxopyrrolidine urea FPR2 agonists
BMY
Bristol-Myers Squibb Company
utilityGoogle Patents ↗

The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 4:59 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Clinical trial updates · FDA approvals and clearances